Stay updated on PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page.

Latest updates to the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedNew metadata entries were added indicating the last known status, the investigator Yanhong Deng from Sun Yat-sen University, the date by 2023-10, and verification status.SummaryDifference0.8%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.SummaryDifference4%

- Check44 days agoChange DetectedUpgrade to version v3.1.0 with a new identifier and contact (dengyanh@mail.sysu.edu.cn), replacing the previous v3.0.2 version.SummaryDifference0.1%

- Check59 days agoChange DetectedVersion bumped to v3.0.2; old v3.0.1 tag removed and the 'Back to Top' element deleted.SummaryDifference0.2%

- Check66 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check73 days agoChange DetectedThe web page has added significant information regarding the facility name, location, and relevant publications, while removing various location details and drug information.SummaryDifference9%

Stay in the know with updates to PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page.